FDA Inspection 884359 — Agnesian Healthcare IRB

Agnesian Healthcare IRB — FEI 3009793893

The FDA completed an inspection of Agnesian Healthcare IRB on June 17, 2014 in Fond Du Lac, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 17, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Fond Du Lac, WI (United States)

Additional Details

IRB

Citations

IDCFRDescription
731621 CFR 56.115(a)(4)Copies of IRB/CI correspondence
731821 CFR 56.115(a)(2)Minutes of IRB meetings
732021 CFR 56.109(e)IRB approvals/disapprovals - general